As of today (2025-07-15), Ocugen's share price is $1.07. Ocugen's Tangible Book per Share of Mar. 2025 for the quarter that ended in Mar. 2025 was $0.05. Hence, Ocugen's Price to Tangible Book Ratio of today is 19.81.
The historical rank and industry rank for Ocugen's Price-to-Tangible-Book or its related term are showing as below:
OCGN'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.48 Med: 4.05 Max: 49.42
Current: 21.4
During the past 13 years, Ocugen's highest Price to Tangible Book Ratio was 49.42. The lowest was 1.48. And the median was 4.05.
OCGN's Price-to-Tangible-Book is ranked worse than 92.15% of 1198
companies
in the Biotechnology industry
Industry Median: 3.045
vs OCGN: 21.40
A closely related ratio is called PB Ratio. As of today, Ocugen's share price is $1.07. Ocugen's Book Value per Sharefor the quarter that ended in Mar. 2025 was $0.05. Hence, Ocugen's P/B Ratio of today is 19.81.
Ocugen Price-to-Tangible-Book Historical Data
The historical data trend for Ocugen's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Ocugen's Price-to-Tangible-Book
For the Biotechnology subindustry, Ocugen's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ocugen's Price-to-Tangible-Book Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ocugen's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Ocugen's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Ocugen Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of Ocugen's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OCGN has been successfully added to your 